Skip to main content

Table 1 Patient demographics, symptoms, and PAVMs treated in groups A and B

From: Embolisation of pulmonary arteriovenous malformations using high-frequency jet ventilation: benefits of minimising respiratory motion

Group

Number of patients

Demographics

Symptoms

Number of PAVMs treated

PAVM location

Embolisation devices

A (HFJV)

5

Age 47.2 ± 11.7 years (34–57 years)

2 males, 3 females

4/5 (80%)

1 prior TIA

3 dyspnoea

12 simple

RLL (n = 4)

RML (n = 1)

RUL (n = 1)

LLL (n = 4)

LUL (n = 2)

6.5-mm MVP (n = 4), vascular plug (n = 5), coils (n = 3)

B (IPPV)

10

Age 41.5 ± 12.4 years (27–65 years)

5 male, 5 female

7/10 (70%)

1 prior TIA

6 dyspnoea

15 (14 simple, 1 complex)

RLL (n = 3)

RML (n = 5)

RUL (n = 2)

LLL (n = 3)

LUL (n = 2)

6.5-mm MVP (n = 4), vascular plug (n = 3), coils (n = 8)

  1. Ages are given as mean ± standard deviation (range). HFJV High-frequency jet ventilation, IPPV Intermittent positive pressure ventilation, LLL/LUL Left lower/upper lobes, MVP Microvascular plug, RLL/RML/RUL Right lower/middle/ upper lobes, TIA Transient ischemic attack